Skip to main content

GST to hit GSK Consumer's global growth

GST to hit GSK Consumer's global growth
UK healthcare company GlaxoSmithKline Consumer's growth globally could ease in 2018 due to the impact of India's Goods & Services Tax, the pruning of its product offerings and competitive pressure.
"In 2018, we continue to expect low single-digit growth from consumer after factoring in the impact of tail brand divestments, the impact of GST in India, and the TDS generic (competitive pressures in the US), which in aggregate are expected to reduce growth by about 1.5% points on a reported basis," GSK global chief financial officer Simon Dingemans said on an earnings call over the weekend.
He added that the company remains confident in the long-term profile of the consumer business. GSK products sold in India include Boost, Horlicks, Crocin and Iodex. India rolled out its biggest tax reform — a unified tax regime under GST — on July 1. Its introduction initially disrupted supplies and companies reported a slowdown in sales as distributors and wholesalers cleared stocks during the transition period. Some wholesalers took time to upgrade systems to become GST-compliant.
India is GSK ConsumerBSE 0.12 %'s second-largest market globally, after the US. The UK company reported a 3% sales increase to over Rs 30 billion for 2017, with a 5% profit growth across its pharmaceuticals, consumer and vaccine businesses, which it attributed to group's operating margin accretion, improved earnings and cash flows.
"Consumer delivered low single-digit growth despite headwinds. Q4 saw better consumption than we'd expected in some of our key markets. The international region also benefited from comparison to a weak fourth quarter last year, which was impacted by demonetisation in India," Dingemans said. Demonetisation, or the note ban in November 2016, led to crippling of cash flow across channels.
GSK CEO Emma Walmsley said that for its consumer healthcare business, the company's sales momentum improved throughout the year with strong performances in wellness and oral health "offsetting the impact of a weak US season and competitive pressures in allergy, as well as divestments and the implementation of GST in India."
The Economic Times, New Delhi, 12th February 2018

Comments

Popular posts from this blog

Shrinking footprints of foreign banks in India

Shrinking footprints of foreign banks in India Foreign banks are increasingly shrinking their presence in India and are also becoming more conservative than private and public sector counterparts. While many of them have sold some of their businesses in India as part of their global strategy, some are trying to keep their core expertise intact. Others are branching out to newer areas to continue business momentum.For example, HSBC and Barclays Bank in India have got out of the retail business, whereas corporate-focused Standard Chartered Bank is now trying to increase its focus on retail “Building a retail franchise is a huge exercise and takes a long time. You cannot afford to lose it,” said Shashank Joshi, Bank of Tokyo-Mitsubishi UFJ’s India head.According to the Reserve Bank of India (RBI) data, foreign banks’ combined loan book shrunk nearly 10 per cent from Rs 3.78 trillion in fiscal 2015-16 to Rs 3.42 trillion last financial year. The banking industry, which includes foreign banks…

RBI rushes in to prop up falling rupee

RBI rushes in to prop up falling rupee India’s central bank reportedly intervened in the currency markets on Monday to prevent a further slide in the local unit, which breached the 67 mark to a dollar for the first time in 15 months amid a widening trade gap and runaway import bills fuelled by high crude-oil prices. Some state-owned banks were seen selling dollars aggressively, interventions that market dealers attributed to the central bank’s strategy to stem the decline of the Indian rupee against the US currency. The rupee is the worst performing among a dozen Asian monetary units in the past three months. It lost 4.25 per cent to the dollar during the period, show data from Bloomberg. On Monday, the Reserve Bank of India (RBI) is said to have sold about Rs 800 million collectively on the spot and exchange traded futures markets, dealers said. An email sent to RBI remained unanswered until the publication of this report. The currency market has seen such a strong central bank interven…

GST Refund of Rs 20,000 Cr Pending: Exporters’ Body

GST Refund of Rs  20,000 Cr Pending: Exporters’ Body Refund of over Rs 20,000 crore on account of Goods and Services Tax (GST) is pending with the government with more than half the amount stuck as input tax credit, Federation of Indian Export Organisations said on Tuesday. While claims over Rs7,000 crore were cleared in March, the amount was Rs 1,000 crore in April.However, after exporters’ request, the GST council and tax department are organizing a second phase of Special Refund Fortnight starting May 31, which will enable exporters to draw their refunds at a speedy pace. Many exporters have been unable to file the refund of input tax credit due to technical glitches, exports and claim happened in different months. The major challenge lies on ITC refund especially because the process is partly electronic and partly manual which is cumbersome and add to the transaction cost, the exporters’ body said. On IGST, refunds are getting delayed due to airline and shipping companies not submitt…